Relapsing demyelinating disease after chicken pox in a child
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Post-infectious encephalomyelitis (PIE), an inflammatory demyelinating disorder, usually begins days to weeks after virus (usually measles, Epstein–Barr virus [EBV], cytomegalovirus [CMV], or varicella zoster virus [VZV]) or mycoplasma infection, and after vaccination with hepatitis B virus,1 Bordetella pertussis, and possibly influenza virus.2 The mechanism by which the infectious agent triggers demyelination is uncertain.
Case report.
Two days after varicella infection, a 3-year-old girl developed fever, confusion, lethargy, and status epilepticus. CSF was acellular with normal protein and glucose, without oligoclonal bands (OGBs) or amplifiable VZV DNA, and no VZV IgM or IgG antibody in serum or CSF. Brain CT revealed diffuse white matter edema. After IV treatment with ceftriaxone, acyclovir, clonazepam, and phenobarbital, seizures stopped and mental status was normal. Neurologic signs included increased DTRs, greater on the left, and ankle clonus bilaterally.
Twenty days later, she became febrile. Neurologic signs consisted of ataxia with dysmetria bilaterally and intention tremor in the arms. Serum contained VZV IgM antibody, and VZV IgG was 6,800 international units (IU) per liter (normal < 50 IU/L). There was no amplifiable VZV DNA in blood. CSF was acellular, protein 31 mg%; …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Mark Burish and Dr. Emmanuelle Schindler
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Effects of natalizumab therapy on intrathecal antiviral antibody responses in MSFabienne Largey, Ivan Jelcic, Mireia Sospedra et al.Neurology: Neuroimmunology & Neuroinflammation, September 25, 2019 -
Articles
The spectrum of antecedent infections in Guillain-Barré syndromeA case-control studyB. C. Jacobs, P. H. Rothbarth, F.G.A. van der Meché et al.Neurology, October 01, 1998 -
Articles
Varicella zoster virus vasculopathyAnalysis of virus-infected arteriesM.A. Nagel, I. Traktinskiy, Y. Azarkh et al.Neurology, July 13, 2011 -
Articles
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathyM. A. Nagel, B. Forghani, R. Mahalingam et al.Neurology, February 07, 2007